The Wall Street Journal
The Drug Industry Is Having Its Own DeepSeek Moment — It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S. counterparts.
China’s Firms Are Bleeding Cash—and Vulnerable to Trump’s Trade War — Companies across the country are bleeding cash as they struggle with overcapacity and weak spending in a slumping economy, leaving them vulnerable to tariffs.
The Financial Times
Rep
LISTEN NOW
Face-Off: U.S. vs. China
A podcast about the turbulent relationship between the world's two superpowers, the two men who run them, and the vital issues that affect us all.